Award
Delivery Order #SPE2DR26FMKL3
Short-Term Delivery Order for Midazolam Hydrochloride to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$8.50
Ceiling
$8.50
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FMKL3
NAICS
424210
This award is a delivery order contract granted to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical products and services. The contract focuses on the procurement of Midazolam Hydrochloride, a critical pharmaceutical utilized in healthcare settings. Awarded as part of an existing indefinite delivery vehicle (IDV) contract supporting the Pharmaceutical PV Division, this short-term agreement ensures continued supply of essential medications. The contract facilitates timely delivery within a narrow timeframe, highlighting the agency's ongoing commitment to maintaining adequate pharmaceutical inventories. This award was likely issued under the umbrella of the existing competitive IDV contract, ensuring efficiency and compliance with procurement standards. The work is scheduled for completion within a two-day period, illustrating a rapid-response acquisition addressing immediate pharmaceutical needs.
Description
4571171691! MIDAZOLAM HYDROCHLORI